glp 1 ras Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Comparison of short-acting versus long-acting

A Morgan Stanley survey conducted earlier this year among GLP-1 drug users including those using the treatments for diabetes found that about two-thirds of respondents had their medication fully covered by insurance

Withaar, C

What Makes Retatrutide Powder a Breakthrough Triple-Agonist API

Combination therapy with metformin is common and often effective, while alternatives may better fit those needing weight loss or cardiorenal benefits

Buse, J

Persistence and Adherence to Treatment In 7068 individuals after PSM, the overall 1-year rates of persistence and adherence to treatment were 85.6% (6048) and 70.1% (4954), respectively (Table 2)